Cargando…

The Biological Potential Hidden in Inclusion Bodies

Inclusion bodies (IBs) are protein nanoclusters obtained during recombinant protein production processes, and several studies have demonstrated their potential as biomaterials for therapeutic protein delivery. Nevertheless, IBs have been, so far, exclusively sifted by their biological activity in vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gifre-Renom, Laia, Seras-Franzoso, Joaquin, Rafael, Diana, Andrade, Fernanda, Cano-Garrido, Olivia, Martinez-Trucharte, Francesc, Ugarte-Berzal, Estefania, Martens, Erik, Boon, Lise, Villaverde, Antonio, Opdenakker, Ghislain, Schwartz, Simó, Arís, Anna, Garcia-Fruitós, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076398/ https://www.ncbi.nlm.nih.gov/pubmed/32075316 http://dx.doi.org/10.3390/pharmaceutics12020157

Ejemplares similares

Recombinant Protein-Based Nanoparticles: Elucidating Their Inflammatory Effects In Vivo and Their Potential as a New Therapeutic Format
por: Gifre-Renom, Laia, et al.
Publicado: (2020)

Isolation of cell-free bacterial inclusion bodies
por: Rodríguez-Carmona, Escarlata, et al.
Publicado: (2010)

A new approach to obtain pure and active proteins from Lactococcus lactis protein aggregates
por: Gifre-Renom, L., et al.
Publicado: (2018)

Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities
por: Boon, Lise, et al.
Publicado: (2016)

Lactiplantibacillus plantarum: a new example of inclusion body producing bacteria
por: Baltà-Foix, Ricardo, et al.
Publicado: (2023)

Endotoxemia shifts neutrophils with TIMP-free gelatinase B/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1
por: Vandooren, Jennifer, et al.
Publicado: (2017)

EDTA/gelatin zymography method to identify C1s versus activated MMP‐9 in plasma and immune complexes of patients with systemic lupus erythematosus
por: Ugarte‐Berzal, Estefania, et al.
Publicado: (2018)

Selecting Subpopulations of High-Quality Protein Conformers among Conformational Mixtures of Recombinant Bovine MMP-9 Solubilized from Inclusion Bodies
por: Carratalá, Jose Vicente, et al.
Publicado: (2021)

MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus
por: Ugarte-Berzal, Estefania, et al.
Publicado: (2019)

Packaging protein drugs as bacterial inclusion bodies for therapeutic applications
por: Villaverde, Antonio, et al.
Publicado: (2012)

Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes
por: Cano-Garrido, Olivia, et al.
Publicado: (2015)

Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis
por: Ugarte-Berzal, Estefania, et al.
Publicado: (2018)

Neutrophils and Activated Macrophages Control Mucosal Immunity by Proteolytic Cleavage of Antileukoproteinase
por: Vandooren, Jennifer, et al.
Publicado: (2018)

Trends in recombinant protein use in animal production
por: Gifre, Laia, et al.
Publicado: (2017)

Potential of MMP-9 based nanoparticles at optimizing the cow dry period: pulling apart the effects of MMP-9 and nanoparticles
por: Gifre-Renom, L., et al.
Publicado: (2020)

Gelatinase B/Matrix Metalloproteinase-9 as Innate Immune Effector Molecule in Achalasia
por: Furuzawa-Carballeda, Janette, et al.
Publicado: (2018)

Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms
por: Torrealba, Débora, et al.
Publicado: (2016)

Physiological fibrin hydrogel modulates immune cells and molecules and accelerates mouse skin wound healing
por: Pereira, Rafaela Vaz Sousa, et al.
Publicado: (2023)

Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells
por: Montero, Sara, et al.
Publicado: (2020)

Propeptide glycosylation and galectin‐3 binding decrease proteolytic activation of human proMMP‐9/progelatinase B
por: Boon, Lise, et al.
Publicado: (2018)

Vessel Enlargement in Development and Pathophysiology
por: Gifre-Renom, Laia, et al.
Publicado: (2021)

Editorial: High added-value nanoparticles: Rethinking and recycling cell protein waste
por: Unzueta, Ugutz, et al.
Publicado: (2022)

The chaperone DnaK controls the fractioning of functional protein between soluble and insoluble cell fractions in inclusion body-forming cells
por: González-Montalbán, Nuria, et al.
Publicado: (2006)

Proteoform Analysis of Matrix Metalloproteinase-9/Gelatinase B and Discovery of Its Citrullination in Rheumatoid Arthritis Synovial Fluids
por: Grillet, Bernard, et al.
Publicado: (2021)

Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins
por: García-Fruitós, Elena, et al.
Publicado: (2005)

Organ-Specific Endothelial Cell Differentiation and Impact of Microenvironmental Cues on Endothelial Heterogeneity
por: Gifre-Renom, Laia, et al.
Publicado: (2022)

The Potential of Metalloproteinase-9 Administration to Accelerate Mammary Involution and Boost the Immune System at Dry-Off
por: Parés, Sílvia, et al.
Publicado: (2021)

Extracellular Vesicles as Drug Delivery Systems in Cancer
por: Hernandez-Oller, Laia, et al.
Publicado: (2020)

Bivalent Inhibitor with Selectivity for Trimeric MMP-9 Amplifies Neutrophil Chemotaxis and Enables Functional Studies on MMP-9 Proteoforms
por: Nuti, Elisa, et al.
Publicado: (2020)

Chlorite-Oxidized Oxyamylose (COAM) Has Antibacterial Activity and Positively Affects Skin Wound Healing
por: Pereira, Rafaela Vaz Sousa, et al.
Publicado: (2022)

Learning about protein solubility from bacterial inclusion bodies
por: Martínez-Alonso, Mónica, et al.
Publicado: (2009)

Sterilization Procedure for Temperature-Sensitive Hydrogels Loaded with Silver Nanoparticles for Clinical Applications
por: Rafael, Diana, et al.
Publicado: (2019)

Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies
por: Pesarrodona, Mireia, et al.
Publicado: (2019)

Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study
por: Vandooren, Jennifer, et al.
Publicado: (2017)

Internal Disulfide Bonding and Glycosylation of Interleukin-7 Protect Against Proteolytic Inactivation by Neutrophil Metalloproteinases and Serine Proteases
por: Vandooren, Jennifer, et al.
Publicado: (2021)

Co-production of GroELS discriminates between intrinsic and thermally-induced recombinant protein aggregation during substrate quality control
por: Platas, Gemma, et al.
Publicado: (2011)

Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli
por: Rueda, Fabián, et al.
Publicado: (2016)

Inclusion bodies: a new concept
por: García-Fruitós, Elena
Publicado: (2010)

Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
por: Ulldemolins, Anna, et al.
Publicado: (2021)

Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells
por: Gener, Petra, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g39s6qu93mp3dvnmuif729cuug